Illumina Urinary Pathogen ID/AMR Enrichment Kits for use with Government-Owned Illumina MiSeq Systems

The Medical Readiness Contracting Office - Pacific, part of the Department of the Army Medical Command, intends to make a sole source award to Illumina, Inc. for Urinary Pathogen ID/AMR Enrichment Kits specifically designed for use with Government-Owned Illumina MiSeq Systems at Tripler Army Medical Center in Hawaii. The contract will be awarded under FAR 13.106-1(b)(1), which allows for single-source procurement when only one source is reasonably available for purchases not exceeding the simplified acquisition threshold. Potential respondents are required to submit comprehensive and detailed information demonstrating their qualifications to supply the required products, with all questions and responses to be emailed to keary.haubner.civ@health.mil. The notice was posted on April 30, 2025, with responses due by May 7, 2025. Importantly, this notice does not obligate the government to award a contract and respondents are cautioned against including any proprietary, classified, or sensitive information in their submissions.

The pre-solicitation notice indicates no specific set-aside designation for this procurement, and the contract is categorized under NAICS code 541714 for Research and Development in Biotechnology. The procurement will utilize Product Service Code (PSC) 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. While specific award values or precise quantities are not disclosed, the procurement is structured as a sole source award directly to Illumina, Inc. The contract appears focused on acquiring specialized diagnostic kits for pathogen identification and antimicrobial resistance testing. The government's approach suggests a targeted, specific procurement to support medical diagnostic capabilities at the Tripler Army Medical Center, with a clear emphasis on obtaining specialized biotechnology research and diagnostic products from a single, preferred manufacturer.